A painful inheritance - Patient perspectives on living with polycystic kidney disease: Thematic synthesis of qualitative research

Nephrology Dialysis Transplantation

Volumn 30, Issue 5, 2015, Pages 790-800

  Tong, Allison ^a,b   Rangan, Gopala K ^c   Ruospo, Marinella ^d,e   Saglimbene, Valeria ^d   Strippoli, Giovanni F M ^a,d,e   Palmer, Suetonia C ^f   Tunnicliffe, David J ^a,b   Craig, Jonathan C ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d Diaverum Academy   (Sweden)

^e UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^f UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

patient centred outcomes; polycystic kidney disease; qualitative research; quality of life

Indexed keywords

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; DAILY LIFE ACTIVITY; DECISION MAKING; FEMALE; GUILT; HUMAN; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT AUTONOMY; PATIENT CARE; PATIENT COUNSELING; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITATIVE RESEARCH; QUALITY OF LIFE; RESPONSIBILITY; SELF CARE; ADOLESCENT; AGED; CHILD; MIDDLE AGED; PAIN; POLYCYSTIC KIDNEY DISEASES; PROGNOSIS; PSYCHOLOGY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DECISION MAKING; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; POLYCYSTIC KIDNEY DISEASES; PROGNOSIS; QUALITATIVE RESEARCH; QUALITY OF LIFE; SELF CARE; YOUNG ADULT;

EID: 84929576330     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv010     Document Type: Article

References (58)

1. Shaw C, Simms RJ, Pitcher D et al. Epidemiology of patients in England and Wales with autosomal dominant polycystic kidney disease and endstage renal failure. Nephrol Dial Transplant 2014; 29: 1910-1918
2. Spithoven EM, Kramer A, Meijer E et al. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival: an analysis of data from the ERA-EDTA Registry. Nephrol Dial Transplant 2014; 29(S4): 15-25
3. Reule S, Sexton DJ, Solid CA et al. ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010. Am J Kidney Dis 2014; 64: 592-599
4. Helal I, McFann K, Reed B et al. Changing referral characteristics of patients with autosomal dominant polycystic kidney disease. Am J Med 2013; 126: 832 e837-832.e811
5. Alam A, Perrone RD. Management of ESRD in patients with autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 2010; 17: 164-172
6. Pei Y. Diagnostic approach in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2006; 1: 1108-1114
7. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 2007; 369: 1287-1301
8. Miskulin DC, Abebe KZ, Chapman AB et al. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: A cross-sectional study. Am J Kidney Dis 2014; 63: 214-226
9. Suwabe T, Ubara Y, Mise K et al. Quality of life of patients with ADPKDToranomon PKD QOL study: cross-sectional study. BMC Nephrol 2013; 14: 179
10. Santoro D, Satta E, Messina S et al. Pain in end-stage renal disease: A frequent and neglected clinical problem. Clin Nephrol 2013; 79(S1): 2-11
11. Rizk D, Jurkovitz C, Veledar E et al. Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis. Clin J Am Soc Nephrol 2009; 4: 560-566
12. Jankowska M, Walerzak A, Debska-Slizien A et al. The acceptance of illness and the perception of anger, anxiety and depression in early stage of autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2013; 28: i28
13. Sujansky E, Beeler Kreutzer S, Johnson AM et al. Attitudes of at-risk and affected individuals regarding presymptomatic testing for autosomal dominant polycystic kidney disease. Am J Med Gen 1990; 35: 510-515
14. Clarke A, Sarangi S, Verrier-Jones K. Voicing the lifeworld: parental accounts of responsibility in genetic consultations for polycystic kidney disease. Soc Sci Med 2011; 72: 1743-1751
15. Carr A, Makin A, Baker A. Do we under-estimate the physical and emotional impact of early stage ADPKD? Evidence for a discrepancy between patient experience and physician perceptions. Nephrol Dial Transplant 2014; 29: iii75-iii76
16. Torres VE, Abebe KZ, Chapman AB et al. Angiotensin blockade in late autosomal dominant polycystic kidney disease. N Eng J Med 2014; 371: 2267-2276
17. Schrier RW, Abebe KZ, Perrone RD et al. Blood pressure in early autosomal dominant polycystic kidney disease. N Eng JMed 2015; 372: 975-977
18. Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol 2008; 8: 45
19. Tong A, Flemming K, McInnes E et al. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol 2012; 12: 181
20. Tong A, Sainsbury P, Craig JC. Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007; 19: 349-357
21. Barlow-Stewart K, Taylor SD, Treloar SA et al. Verification of consumers' experiences and perceptions of genetic discrimination and its impact on utilization of genetic testing. Gen Med 2009; 11: 193-201
22. Cox SM, Starzomski RC. Genes and geneticization? The social construction of autosomal dominant polycystic kidney disease. New Genet Soc 2004; 23: 137-166
23. Curtin RB, Mapes D, Petillo M et al. Long-term dialysis survivors: A transformational experience. Qual Health Res 2002; 12: 609-624
24. Davison SN, Simpson C. Hope and advance care planning in patients with end stage renal disease: qualitative interview study. BMJ 2006; 333: 886
25. Heiwe S, Bjuke M. "An evil heritage": interview study of pain and autosomal dominant polycystic kidney disease. Pain Manage Nurs 2009; 10: 134-141
26. Hodgkinson KA, Kerzin-Storrar L, Watters EA et al. Adult polycystic kidney disease: knowledge, experience, and attitudes to prenatal diagnosis. J Med Genet 1990; 27: 552-558
27. Kielstein R. ADPKD and the clinical and ethical challenges of predictive medicine. Eur J Genet Soc 1995; 1: 2-6
28. Krespi R, Bone M, Ahmad R et al. Haemodialysis patients' beliefs about renal failure and its treatment. Patient Educ Couns 2004; 53: 189-196
29. Lindsay H, MacGregor C, Fry M. The experience of living with chronic illness for the haemodialysis patient. Health Soc Rev 2014: doi: 10. 5172/ hesr.2014.4344
30. Lopez-Vargas PA, Tong A, Phoon RKS et al. Knowledge deficit of patients with stage 1-4 CKD: A focus group study. Nephrology 2014; 19: 234-243
31. Manjoney DM, McKegney FP. Individual and family coping with polycystic kidney disease: The harvest of denial. Int J Psychiatry Med 1978-79; 9: 19-31
32. Manias E, Williams A. Communication between patients with chronic kidney disease and nurses about managing pain in the acute hospital setting. J Clin Nurs 2007; 16: 358-367
33. Martin LS. UsingWatson's theory to explore the dimensions of adult polycystic kidney disease. ANNA J 1991; 18: 493-496
34. McAllister M, Payne K, Nicholls S et al. Improving service evaluation in clinical genetics: identifying effects of genetic diseases on individuals and families. J Genet Couns 2007; 16: 71-83
35. Monaro S, Stewart G, Gullick J. A 'lost life': coming to terms with haemodialysis. J Clin Nurs 2014; 23: 3262-3273
36. Rifkin DE, Laws MB, RaoMet al. Medication adherence behavior and priorities among older adults with CKD: A semistructured interview study. Am J Kidney Dis 2010; 56: 439-446
37. Shepherd M. Dimensions of personal loss and gain associated with a rare genetic type of diabetes. Illness, Crisis & Loss 2003; 11: 362-376
38. Strunin L, Stone M, Jack B. Understanding rehospitalization risk: can hospital discharge be modified to reduce recurrent hospitalization? J Hosp Med 2007; 2: 297-304
39. Trachy K. Suffering and end stage renal disease. Loss, Grief & Care 1986; 1: 69-78
40. Wilkie P, Markova I, Forbes C et al. Consumers' attitudes towards genetic counselling in adult polycystic disease of the kidney. Int J Rehab Res 1985; 8: 473-475
41. Stake RE. Qualitative case studies. In: Denzin NK, Lincoln YS, eds. Strategies of Qualitative Inquiry. Sage: Thousand Oaks, CA, 2008.
42. Hogan MC, Norby SM. Evaluation and management of pain in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 2010; 17: e1-16
43. Bajwa Z, Supta S, Warfield CA et al. Pain management in polycystic kidney disease. Kidney Int 2001; 60: 1631-1644
44. Bajwa ZH, Sial KA, Malik AB et al. Pain patterns in patients with polycystic kidney disease. Kidney Int 2004; 66: 1561-1569
45. Keefe FJ, Porter L, Somers T et al. Psychosocial interventions for managing pain in older adults: outcomes and clinical implications. Br J Anaesth 2013; 111: 89-94
46. Eccleston C, Morley SJ, Williams AC. Psychological approaches to chronic pain management: evidence and challenges. Br J Anaesth 2013; 111: 59-63
47. Matthias MS, McGuire AB, Kukla M et al. A brief peer support intervention for veterans with chronic musculoskeletal pain: A pilot study of feasibility and effectiveness. Pain Med 2014. doi: 10. 1111/pme.12571
48. Tse MM, Lee PH, Ng SM et al. Peer volunteers in an integrative pain management program for frail older adults with chronic pain: study protocol for a randomized controlled trial. Trials 2014. doi: 10. 1186/1745-6215-1115-1205
49. Ruehlman LS, Karoly P, Enders C. A randomized controlled evaluation of an online chronic pain self-management program. Pain 2012; 153: 319-330
50. Nevedal DC, Wang C, Oberleitner L et al. Effects of an individually tailored web-based chronic pain management program on pain severity, psychological health, and functioning. J Med Internet Res 2013; 15: e201
51. Marsick R, Limwongse C, Kodish E. Genetic testing for renal diseases: medical and ethical considerations. Am J Kidney Dis 1998; 32: 934-945
52. Hoedemaekers R, Ten Have H. Geneticization: The Cyprus paradigm. J Med Phil 1998; 23: 274-287
53. Forrest K, Simpson SA, Wilson BJ et al. To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet 2003; 64: 317-326
54. Rowland E, Metcalfe A. Communicating inherited genetic risk between parent and child: A meta-thematic synthesis. Int J Nurs Stud 2013; 50: 870-880
55. Quaid KA, Swenson MM, Sims SL et al. What were you thinking? Individuals at risk for Huntington disease talk about having children. J Genet Couns 2010; 19: 606-617
56. Etchegary H, Fowler K. 'They had the right to know.' Genetic risk and perceptions of responsibility. Psychol Health 2008; 23: 707-727
57. Quaid KA, Sims SL, Swenson MM et al. Living at risk: concealing risk and preserving hope in Huntington disease. J Genet Couns 2008; 17: 117-128
58. Perrone RD, Coons SJ, Cavanaugh K et al. Patient-reported outcomes in clinical trials of CKD-related therapies: report of a symposium sponsored by the national kidney foundation and the U.S. Food and Drug Administration. Am J Kidney Dis 2013; 62: 1046-1057